Bullish Case: At $4.72 and 0.4x book, ANGI has deep-value mean-reversion support; the $350-role AI cost cuts ($70-80M annual savings) could expand margins if execution lands. The term structure's steep backwardation (136% Sep IV vs 84% Feb) prices near-term fear, not permanent decline—historical pattern favors choppy stabilization rather than trend continuation, and Feb 2027 $5 calls at ~83% IV embed cheap convexity for any re-rating.

Bearish Case: Helium's AI forecast is -4.32% with a historically negative correlation (-0.2) to realized moves; puts traded 590% more volume than calls—unambiguous hedging flow. Down 72.5% YoY and 22.6% in 60 days, the return surface's thick bands sit at negative % returns, JPMorgan initiated Underweight, and revenue is down 40%+ since 2022. Rich 2.50-strike put IV (169-269%) signals genuine left-tail dilution/impairment risk.

Potential Outcomes:

1. 38% Drift $4.0–$4.8 by Dec: churn/margin overhang persists; near-term IV stays elevated, Feb IV mean-reverts lower. Falsifier: reclaim of $5.50 with fading front IV.
2. 27% Stabilization $4.8–$5.8: cost-savings evidence lands; front IV decays post-9/18–10/17 expiries. Falsifier: put volume ratio stays >300% of calls.
3. 20% Tail <$4.0: dilution/impairment or SPY risk-off spillover; 2.50-put wing IV already signals this.
4. 10% Re-rating $5.8–$7.0: margin beat plus short squeeze.
5. 5% Spike >$7: unexpected catalyst; call skew flips.

September 12, 2026